Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fulcrum Therapeutics

2.83
+0.07002.54%
Post-market: 2.830.00000.00%16:30 EDT
Volume:246.37K
Turnover:697.77K
Market Cap:152.76M
PE:-18.04
High:2.90
Open:2.71
Low:2.71
Close:2.76
Loading ...
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Feb 25, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 25, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 24, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Sep 25, 2024

Major Issues Report

Form 8-K - Current report
Sep 20, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 16, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 12, 2024

Major Issues Report

Form 8-K - Current report
Aug 23, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 22, 2024

Major Issues Report

Form 8-K - Current report
Jul 31, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 31, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jul 31, 2024

Major Issues Report

Form 8-K - Current report